Four new protein-binding platinum (II) complexes, 10, 11, 21, 22, in which the dichloroplatinum moiety is coordinated either to a carbon-substituted or a nitrogen-substituted ethylene diamino ligand, were prepared in ten-step syntheses. According to pH-dependent stability studies with strictly related compounds, 11 and 22 exhibit acid-sensitive properties.
Introduction
Cisplatin and carboplatin are potent antineoplastic drugs which are widely used in anticancer chemotherapy. They show their best results in the treatment of testicular and ovarian carcinoma and are also effective against bladder tumours and tumours of the head and neck ]. However, both platinum complexes do not accumulate in tumour tissues but are distributed rapidly throughout the body after parenteral administration causing several side-effects such as nephrotoxicity, myelotoxicity, ototoxicity, nausea and vomiting ]. Hence, a major goal in anticancer chemotherapy is the development of drug delivery systems that transport the drug to the tumour while largely sparing the healthy tissues of the body. In recent years, numerous preclinical studies have shown that macromolecules such as synthetic polymers and serum proteins are taken up by tumour tissue [2] . These polymers can accumulate in solid tumours due to an enhanced vascular permeability of tumour blood vessels for circulating macromolecules combined with a lacking lymphatic drainage system in the tumour. Following this targeting strategy, we have developed several drug protein conjugates with organic anticancer drugs, e.g. with anthracyclines or the alkylating agent chlorambucil [3] [4] [5] [6] [7] [8] [9] [10] . In order to bind an active cis-configurated platinum(II) complex to the surface of a macromolecular carrier, we set out to design appropriate ligands that are able to form a complex with platinum(II) and are also able to bind to the respective macromolecule as shown by the general structure in In 1998, we reported on two platinum complexes in which the platinum moiety was bound to a spacer through a stable aromatic or aliphatic ester bond and also contained a maleimide group that is able to react specifically with thiolated macromolecules (see Figure 2 ) 11 ]. However, recent studies in our group have revealed that the chemical bond between the drug and the carrier plays a crucial role for in vitro and in vivo activity. In our protein conjugates realised with anthracyclines or alkylating agents, an acid-sensitive linker was used which acts as a predetermined breaking-point .releasing the protein-bound drug either in the acidic environment of tumour tissue or in the acidic endosomal or lysosomal compartments after cellular uptake ofthe conjugate by the tumour cell [3, 10] .
In subsequent biological studies, we were able to establish a correlation between the acid-sensitivity of the chemical link and the antitumour activity of the conjugates: Drug protein conjugates in which the drug was bound to the protein through an acid-sensitive carboxylic hydrazone bond showed high in vitro and in vivo activity, whereas conjugates containing an ester or amide bond showed only marginal efficacy [4] [5] [6] [7] 9 ].
Carboxylic hydrazones have proven very useful as predetermined breaking-points because they are sufficiently stable at pH 7.4 thus preventing the drug from being released in the blood stream-and they also show acid-sensitive properties in a pH-range which is common in most tumour tissues and in relevant organelles oftumour cells (pH range 4-6.5 (11) 0.14 mmol K2PtCI4 were dissolved in 20 ml of DMF/water (80:20) and treated under stirring in the dark with 0.14 mmol of 8 or 9 dissolved in 10 ml DMF/water. The solution was stirred at room temperature until the colour changed from red to yellow. Upon addition of 40 ml of water the platinum complexes 10 and 11 precipitated. The suspension was kept cool for 5 h to 4 C to complete precipitation. The (16) 9.87 mmol 12, 9.0 mmol of 13 or 14 and 0.1 mmol N,N-dimethylaminopyridine (12 mg) were dissolved in 100 ml THF and 10 mmol N,N'-dicyclohexylcarbodiimide (2.1 g), dissolved in 20 ml THF, were then added dropwise under stirring at 4 C. The solution was stirred for 2 h at 4 C, then for further 12 h at room temperature and finally dicyclohexyl urea was filtered off. The filtrate was evaporated to dryness, dissolved in 100 ml ethyl acetate and washed twice with 100 ml of a saturated NaHCO3 solution and then twice with 100 ml water. The organic layer was dried over sodium sulfate and concentrated to a volume of 50 ml.
n-hexane was added until a slight turbidity remained. In the cold at 4 C, colourless crystals formed yielding 2 
